Global Drug based on CAR T-Cell Market Growth (Status and Outlook) 2025-2031
The global Drug based on CAR T-Cell market size is predicted to grow from US$ 430 million in 2025 to US$ 655 million in 2031; it is expected to grow at a CAGR of 7.3% from 2025 to 2031.
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Drug based on CAR T-Cell Industry Forecast” looks at past sales and reviews total world Drug based on CAR T-Cell sales in 2024, providing a comprehensive analysis by region and market sector of projected Drug based on CAR T-Cell sales for 2025 through 2031. With Drug based on CAR T-Cell sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug based on CAR T-Cell industry.
This Insight Report provides a comprehensive analysis of the global Drug based on CAR T-Cell landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Drug based on CAR T-Cell portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug based on CAR T-Cell market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug based on CAR T-Cell and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug based on CAR T-Cell.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug based on CAR T-Cell market by product type, application, key players and key regions and countries.
Segmentation by Type:
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Drug based on CAR T-Cell Industry Forecast” looks at past sales and reviews total world Drug based on CAR T-Cell sales in 2024, providing a comprehensive analysis by region and market sector of projected Drug based on CAR T-Cell sales for 2025 through 2031. With Drug based on CAR T-Cell sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug based on CAR T-Cell industry.
This Insight Report provides a comprehensive analysis of the global Drug based on CAR T-Cell landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Drug based on CAR T-Cell portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug based on CAR T-Cell market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug based on CAR T-Cell and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug based on CAR T-Cell.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug based on CAR T-Cell market by product type, application, key players and key regions and countries.
Segmentation by Type:
- CD19-targeted
- BCMA-targeted
- Lymphoma
- Multiple Myeloma
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Gilead Sciences
- Bristol-Myers Squibb
- J & J
- JW Therapeutics
- FOSUNKite
- CARsgen Therapeutics (Pipeline)
- CARsgen Therapeutics
- Autolus Therapeutics
- Sorrento Therapeutics
- Mustang Bio
- Bluebird Bio
- Cellectis
- Allogene Therapeutics
- Celyad
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug based on CAR T-Cell Market Size (2020-2031)
2.1.2 Drug based on CAR T-Cell Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Drug based on CAR T-Cell by Country/Region (2020, 2024 & 2031)
2.2 Drug based on CAR T-Cell Segment by Type
2.2.1 CD19-targeted
2.2.2 BCMA-targeted
2.3 Drug based on CAR T-Cell Market Size by Type
2.3.1 Drug based on CAR T-Cell Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Drug based on CAR T-Cell Market Size Market Share by Type (2020-2025)
2.4 Drug based on CAR T-Cell Segment by Application
2.4.1 Lymphoma
2.4.2 Multiple Myeloma
2.5 Drug based on CAR T-Cell Market Size by Application
2.5.1 Drug based on CAR T-Cell Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Drug based on CAR T-Cell Market Size Market Share by Application (2020-2025)
3 DRUG BASED ON CAR T-CELL MARKET SIZE BY PLAYER
3.1 Drug based on CAR T-Cell Market Size Market Share by Player
3.1.1 Global Drug based on CAR T-Cell Revenue by Player (2020-2025)
3.1.2 Global Drug based on CAR T-Cell Revenue Market Share by Player (2020-2025)
3.2 Global Drug based on CAR T-Cell Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DRUG BASED ON CAR T-CELL BY REGION
4.1 Drug based on CAR T-Cell Market Size by Region (2020-2025)
4.2 Global Drug based on CAR T-Cell Annual Revenue by Country/Region (2020-2025)
4.3 Americas Drug based on CAR T-Cell Market Size Growth (2020-2025)
4.4 APAC Drug based on CAR T-Cell Market Size Growth (2020-2025)
4.5 Europe Drug based on CAR T-Cell Market Size Growth (2020-2025)
4.6 Middle East & Africa Drug based on CAR T-Cell Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Drug based on CAR T-Cell Market Size by Country (2020-2025)
5.2 Americas Drug based on CAR T-Cell Market Size by Type (2020-2025)
5.3 Americas Drug based on CAR T-Cell Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug based on CAR T-Cell Market Size by Region (2020-2025)
6.2 APAC Drug based on CAR T-Cell Market Size by Type (2020-2025)
6.3 APAC Drug based on CAR T-Cell Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Drug based on CAR T-Cell Market Size by Country (2020-2025)
7.2 Europe Drug based on CAR T-Cell Market Size by Type (2020-2025)
7.3 Europe Drug based on CAR T-Cell Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug based on CAR T-Cell by Region (2020-2025)
8.2 Middle East & Africa Drug based on CAR T-Cell Market Size by Type (2020-2025)
8.3 Middle East & Africa Drug based on CAR T-Cell Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DRUG BASED ON CAR T-CELL MARKET FORECAST
10.1 Global Drug based on CAR T-Cell Forecast by Region (2026-2031)
10.1.1 Global Drug based on CAR T-Cell Forecast by Region (2026-2031)
10.1.2 Americas Drug based on CAR T-Cell Forecast
10.1.3 APAC Drug based on CAR T-Cell Forecast
10.1.4 Europe Drug based on CAR T-Cell Forecast
10.1.5 Middle East & Africa Drug based on CAR T-Cell Forecast
10.2 Americas Drug based on CAR T-Cell Forecast by Country (2026-2031)
10.2.1 United States Market Drug based on CAR T-Cell Forecast
10.2.2 Canada Market Drug based on CAR T-Cell Forecast
10.2.3 Mexico Market Drug based on CAR T-Cell Forecast
10.2.4 Brazil Market Drug based on CAR T-Cell Forecast
10.3 APAC Drug based on CAR T-Cell Forecast by Region (2026-2031)
10.3.1 China Drug based on CAR T-Cell Market Forecast
10.3.2 Japan Market Drug based on CAR T-Cell Forecast
10.3.3 Korea Market Drug based on CAR T-Cell Forecast
10.3.4 Southeast Asia Market Drug based on CAR T-Cell Forecast
10.3.5 India Market Drug based on CAR T-Cell Forecast
10.3.6 Australia Market Drug based on CAR T-Cell Forecast
10.4 Europe Drug based on CAR T-Cell Forecast by Country (2026-2031)
10.4.1 Germany Market Drug based on CAR T-Cell Forecast
10.4.2 France Market Drug based on CAR T-Cell Forecast
10.4.3 UK Market Drug based on CAR T-Cell Forecast
10.4.4 Italy Market Drug based on CAR T-Cell Forecast
10.4.5 Russia Market Drug based on CAR T-Cell Forecast
10.5 Middle East & Africa Drug based on CAR T-Cell Forecast by Region (2026-2031)
10.5.1 Egypt Market Drug based on CAR T-Cell Forecast
10.5.2 South Africa Market Drug based on CAR T-Cell Forecast
10.5.3 Israel Market Drug based on CAR T-Cell Forecast
10.5.4 Turkey Market Drug based on CAR T-Cell Forecast
10.6 Global Drug based on CAR T-Cell Forecast by Type (2026-2031)
10.7 Global Drug based on CAR T-Cell Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Drug based on CAR T-Cell Forecast
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Drug based on CAR T-Cell Product Offered
11.1.3 Novartis Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences Drug based on CAR T-Cell Product Offered
11.2.3 Gilead Sciences Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Gilead Sciences Main Business Overview
11.2.5 Gilead Sciences Latest Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Information
11.3.2 Bristol-Myers Squibb Drug based on CAR T-Cell Product Offered
11.3.3 Bristol-Myers Squibb Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Bristol-Myers Squibb Main Business Overview
11.3.5 Bristol-Myers Squibb Latest Developments
11.4 J & J
11.4.1 J & J Company Information
11.4.2 J & J Drug based on CAR T-Cell Product Offered
11.4.3 J & J Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 J & J Main Business Overview
11.4.5 J & J Latest Developments
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Information
11.5.2 JW Therapeutics Drug based on CAR T-Cell Product Offered
11.5.3 JW Therapeutics Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 JW Therapeutics Main Business Overview
11.5.5 JW Therapeutics Latest Developments
11.6 FOSUNKite
11.6.1 FOSUNKite Company Information
11.6.2 FOSUNKite Drug based on CAR T-Cell Product Offered
11.6.3 FOSUNKite Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 FOSUNKite Main Business Overview
11.6.5 FOSUNKite Latest Developments
11.7 CARsgen Therapeutics (Pipeline)
11.7.1 CARsgen Therapeutics (Pipeline) Company Information
11.7.2 CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Product Offered
11.7.3 CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 CARsgen Therapeutics (Pipeline) Main Business Overview
11.7.5 CARsgen Therapeutics (Pipeline) Latest Developments
11.8 CARsgen Therapeutics
11.8.1 CARsgen Therapeutics Company Information
11.8.2 CARsgen Therapeutics Drug based on CAR T-Cell Product Offered
11.8.3 CARsgen Therapeutics Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 CARsgen Therapeutics Main Business Overview
11.8.5 CARsgen Therapeutics Latest Developments
11.9 Autolus Therapeutics
11.9.1 Autolus Therapeutics Company Information
11.9.2 Autolus Therapeutics Drug based on CAR T-Cell Product Offered
11.9.3 Autolus Therapeutics Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Autolus Therapeutics Main Business Overview
11.9.5 Autolus Therapeutics Latest Developments
11.10 Sorrento Therapeutics
11.10.1 Sorrento Therapeutics Company Information
11.10.2 Sorrento Therapeutics Drug based on CAR T-Cell Product Offered
11.10.3 Sorrento Therapeutics Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Sorrento Therapeutics Main Business Overview
11.10.5 Sorrento Therapeutics Latest Developments
11.11 Mustang Bio
11.11.1 Mustang Bio Company Information
11.11.2 Mustang Bio Drug based on CAR T-Cell Product Offered
11.11.3 Mustang Bio Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Mustang Bio Main Business Overview
11.11.5 Mustang Bio Latest Developments
11.12 Bluebird Bio
11.12.1 Bluebird Bio Company Information
11.12.2 Bluebird Bio Drug based on CAR T-Cell Product Offered
11.12.3 Bluebird Bio Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Bluebird Bio Main Business Overview
11.12.5 Bluebird Bio Latest Developments
11.13 Cellectis
11.13.1 Cellectis Company Information
11.13.2 Cellectis Drug based on CAR T-Cell Product Offered
11.13.3 Cellectis Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Cellectis Main Business Overview
11.13.5 Cellectis Latest Developments
11.14 Allogene Therapeutics
11.14.1 Allogene Therapeutics Company Information
11.14.2 Allogene Therapeutics Drug based on CAR T-Cell Product Offered
11.14.3 Allogene Therapeutics Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Allogene Therapeutics Main Business Overview
11.14.5 Allogene Therapeutics Latest Developments
11.15 Celyad
11.15.1 Celyad Company Information
11.15.2 Celyad Drug based on CAR T-Cell Product Offered
11.15.3 Celyad Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Celyad Main Business Overview
11.15.5 Celyad Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Drug based on CART-Cell Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Drug based on CART-Cell Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of CD19-targeted
Table 4. Major Players of BCMA-targeted
Table 5. Drug based on CART-Cell Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Drug based on CART-Cell Market Size byType (2020-2025) & ($ millions)
Table 7. Global Drug based on CART-Cell Market Size Market Share byType (2020-2025)
Table 8. Drug based on CART-Cell Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Drug based on CART-Cell Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Drug based on CART-Cell Market Size Market Share by Application (2020-2025)
Table 11. Global Drug based on CART-Cell Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Drug based on CART-Cell Revenue Market Share by Player (2020-2025)
Table 13. Drug based on CART-Cell Key Players Head office and Products Offered
Table 14. Drug based on CART-Cell Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Drug based on CART-Cell Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Drug based on CART-Cell Market Size Market Share by Region (2020-2025)
Table 19. Global Drug based on CART-Cell Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Drug based on CART-Cell Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Drug based on CART-Cell Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Drug based on CART-Cell Market Size Market Share by Country (2020-2025)
Table 23. Americas Drug based on CART-Cell Market Size byType (2020-2025) & ($ millions)
Table 24. Americas Drug based on CART-Cell Market Size Market Share byType (2020-2025)
Table 25. Americas Drug based on CART-Cell Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Drug based on CART-Cell Market Size Market Share by Application (2020-2025)
Table 27. APAC Drug based on CART-Cell Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Drug based on CART-Cell Market Size Market Share by Region (2020-2025)
Table 29. APAC Drug based on CART-Cell Market Size byType (2020-2025) & ($ millions)
Table 30. APAC Drug based on CART-Cell Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Drug based on CART-Cell Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Drug based on CART-Cell Market Size Market Share by Country (2020-2025)
Table 33. Europe Drug based on CART-Cell Market Size byType (2020-2025) & ($ millions)
Table 34. Europe Drug based on CART-Cell Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Drug based on CART-Cell Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Drug based on CART-Cell Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa Drug based on CART-Cell Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Drug based on CART-Cell
Table 39. Key Market Challenges & Risks of Drug based on CART-Cell
Table 40. Key IndustryTrends of Drug based on CART-Cell
Table 41. Global Drug based on CART-Cell Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global Drug based on CART-Cell Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global Drug based on CART-Cell Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global Drug based on CART-Cell Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45. Novartis Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 46. Novartis Drug based on CART-Cell Product Offered
Table 47. Novartis Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Novartis Main Business
Table 49. Novartis Latest Developments
Table 50. Gilead Sciences Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 51. Gilead Sciences Drug based on CART-Cell Product Offered
Table 52. Gilead Sciences Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Gilead Sciences Main Business
Table 54. Gilead Sciences Latest Developments
Table 55. Bristol-Myers Squibb Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 56. Bristol-Myers Squibb Drug based on CART-Cell Product Offered
Table 57. Bristol-Myers Squibb Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Bristol-Myers Squibb Main Business
Table 59. Bristol-Myers Squibb Latest Developments
Table 60. J & J Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 61. J & J Drug based on CART-Cell Product Offered
Table 62. J & J Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. J & J Main Business
Table 64. J & J Latest Developments
Table 65. JWTherapeutics Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 66. JWTherapeutics Drug based on CART-Cell Product Offered
Table 67. JWTherapeutics Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. JWTherapeutics Main Business
Table 69. JWTherapeutics Latest Developments
Table 70.FOSUNKite Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 71.FOSUNKite Drug based on CART-Cell Product Offered
Table 72.FOSUNKite Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73.FOSUNKite Main Business
Table 74.FOSUNKite Latest Developments
Table 75. CARsgenTherapeutics (Pipeline) Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 76. CARsgenTherapeutics (Pipeline) Drug based on CART-Cell Product Offered
Table 77. CARsgenTherapeutics (Pipeline) Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. CARsgenTherapeutics (Pipeline) Main Business
Table 79. CARsgenTherapeutics (Pipeline) Latest Developments
Table 80. CARsgenTherapeutics Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 81. CARsgenTherapeutics Drug based on CART-Cell Product Offered
Table 82. CARsgenTherapeutics Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. CARsgenTherapeutics Main Business
Table 84. CARsgenTherapeutics Latest Developments
Table 85. AutolusTherapeutics Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 86. AutolusTherapeutics Drug based on CART-Cell Product Offered
Table 87. AutolusTherapeutics Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. AutolusTherapeutics Main Business
Table 89. AutolusTherapeutics Latest Developments
Table 90. SorrentoTherapeutics Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 91. SorrentoTherapeutics Drug based on CART-Cell Product Offered
Table 92. SorrentoTherapeutics Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. SorrentoTherapeutics Main Business
Table 94. SorrentoTherapeutics Latest Developments
Table 95. Mustang Bio Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 96. Mustang Bio Drug based on CART-Cell Product Offered
Table 97. Mustang Bio Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Mustang Bio Main Business
Table 99. Mustang Bio Latest Developments
Table 100. Bluebird Bio Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 101. Bluebird Bio Drug based on CART-Cell Product Offered
Table 102. Bluebird Bio Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Bluebird Bio Main Business
Table 104. Bluebird Bio Latest Developments
Table 105. Cellectis Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 106. Cellectis Drug based on CART-Cell Product Offered
Table 107. Cellectis Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Cellectis Main Business
Table 109. Cellectis Latest Developments
Table 110. AllogeneTherapeutics Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 111. AllogeneTherapeutics Drug based on CART-Cell Product Offered
Table 112. AllogeneTherapeutics Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. AllogeneTherapeutics Main Business
Table 114. AllogeneTherapeutics Latest Developments
Table 115. Celyad Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 116. Celyad Drug based on CART-Cell Product Offered
Table 117. Celyad Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Celyad Main Business
Table 119. Celyad Latest Developments
LIST OFFIGURES
Figure 1. Drug based on CART-Cell Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drug based on CART-Cell Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Drug based on CART-Cell Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Drug based on CART-Cell Sales Market Share by Country/Region (2024)
Figure 8. Drug based on CART-Cell Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Drug based on CART-Cell Market Size Market Share byType in 2024
Figure 10. Drug based on CART-Cell in Lymphoma
Figure 11. Global Drug based on CART-Cell Market: Lymphoma (2020-2025) & ($ millions)
Figure 12. Drug based on CART-Cell in Multiple Myeloma
Figure 13. Global Drug based on CART-Cell Market: Multiple Myeloma (2020-2025) & ($ millions)
Figure 14. Global Drug based on CART-Cell Market Size Market Share by Application in 2024
Figure 15. Global Drug based on CART-Cell Revenue Market Share by Player in 2024
Figure 16. Global Drug based on CART-Cell Market Size Market Share by Region (2020-2025)
Figure 17. Americas Drug based on CART-Cell Market Size 2020-2025 ($ millions)
Figure 18. APAC Drug based on CART-Cell Market Size 2020-2025 ($ millions)
Figure 19. Europe Drug based on CART-Cell Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Drug based on CART-Cell Market Size 2020-2025 ($ millions)
Figure 21. Americas Drug based on CART-Cell Value Market Share by Country in 2024
Figure 22. United States Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Drug based on CART-Cell Market Size Market Share by Region in 2024
Figure 27. APAC Drug based on CART-Cell Market Size Market Share byType (2020-2025)
Figure 28. APAC Drug based on CART-Cell Market Size Market Share by Application (2020-2025)
Figure 29. China Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 33. India Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Drug based on CART-Cell Market Size Market Share by Country in 2024
Figure 36. Europe Drug based on CART-Cell Market Size Market Share byType (2020-2025)
Figure 37. Europe Drug based on CART-Cell Market Size Market Share by Application (2020-2025)
Figure 38. Germany Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 39.France Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Drug based on CART-Cell Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Drug based on CART-Cell Market Size Market Share byType (2020-2025)
Figure 45. Middle East & Africa Drug based on CART-Cell Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 49.Turkey Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 52. APAC Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 53. Europe Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 55. United States Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 56. Canada Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 57. Mexico Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 58. Brazil Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 59. China Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 60. Japan Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 61. Korea Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 63. India Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 64. Australia Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 65. Germany Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 66.France Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 67. UK Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 68. Italy Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 69. Russia Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 70. Egypt Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 71. South Africa Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 72. Israel Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 73.Turkey Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 74. Global Drug based on CART-Cell Market Size Market ShareForecast byType (2026-2031)
Figure 75. Global Drug based on CART-Cell Market Size Market ShareForecast by Application (2026-2031)
Figure 76. GCC Countries Drug based on CART-Cell Market Size 2026-2031 ($ millions)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug based on CAR T-Cell Market Size (2020-2031)
2.1.2 Drug based on CAR T-Cell Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Drug based on CAR T-Cell by Country/Region (2020, 2024 & 2031)
2.2 Drug based on CAR T-Cell Segment by Type
2.2.1 CD19-targeted
2.2.2 BCMA-targeted
2.3 Drug based on CAR T-Cell Market Size by Type
2.3.1 Drug based on CAR T-Cell Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Drug based on CAR T-Cell Market Size Market Share by Type (2020-2025)
2.4 Drug based on CAR T-Cell Segment by Application
2.4.1 Lymphoma
2.4.2 Multiple Myeloma
2.5 Drug based on CAR T-Cell Market Size by Application
2.5.1 Drug based on CAR T-Cell Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Drug based on CAR T-Cell Market Size Market Share by Application (2020-2025)
3 DRUG BASED ON CAR T-CELL MARKET SIZE BY PLAYER
3.1 Drug based on CAR T-Cell Market Size Market Share by Player
3.1.1 Global Drug based on CAR T-Cell Revenue by Player (2020-2025)
3.1.2 Global Drug based on CAR T-Cell Revenue Market Share by Player (2020-2025)
3.2 Global Drug based on CAR T-Cell Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DRUG BASED ON CAR T-CELL BY REGION
4.1 Drug based on CAR T-Cell Market Size by Region (2020-2025)
4.2 Global Drug based on CAR T-Cell Annual Revenue by Country/Region (2020-2025)
4.3 Americas Drug based on CAR T-Cell Market Size Growth (2020-2025)
4.4 APAC Drug based on CAR T-Cell Market Size Growth (2020-2025)
4.5 Europe Drug based on CAR T-Cell Market Size Growth (2020-2025)
4.6 Middle East & Africa Drug based on CAR T-Cell Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Drug based on CAR T-Cell Market Size by Country (2020-2025)
5.2 Americas Drug based on CAR T-Cell Market Size by Type (2020-2025)
5.3 Americas Drug based on CAR T-Cell Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug based on CAR T-Cell Market Size by Region (2020-2025)
6.2 APAC Drug based on CAR T-Cell Market Size by Type (2020-2025)
6.3 APAC Drug based on CAR T-Cell Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Drug based on CAR T-Cell Market Size by Country (2020-2025)
7.2 Europe Drug based on CAR T-Cell Market Size by Type (2020-2025)
7.3 Europe Drug based on CAR T-Cell Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug based on CAR T-Cell by Region (2020-2025)
8.2 Middle East & Africa Drug based on CAR T-Cell Market Size by Type (2020-2025)
8.3 Middle East & Africa Drug based on CAR T-Cell Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DRUG BASED ON CAR T-CELL MARKET FORECAST
10.1 Global Drug based on CAR T-Cell Forecast by Region (2026-2031)
10.1.1 Global Drug based on CAR T-Cell Forecast by Region (2026-2031)
10.1.2 Americas Drug based on CAR T-Cell Forecast
10.1.3 APAC Drug based on CAR T-Cell Forecast
10.1.4 Europe Drug based on CAR T-Cell Forecast
10.1.5 Middle East & Africa Drug based on CAR T-Cell Forecast
10.2 Americas Drug based on CAR T-Cell Forecast by Country (2026-2031)
10.2.1 United States Market Drug based on CAR T-Cell Forecast
10.2.2 Canada Market Drug based on CAR T-Cell Forecast
10.2.3 Mexico Market Drug based on CAR T-Cell Forecast
10.2.4 Brazil Market Drug based on CAR T-Cell Forecast
10.3 APAC Drug based on CAR T-Cell Forecast by Region (2026-2031)
10.3.1 China Drug based on CAR T-Cell Market Forecast
10.3.2 Japan Market Drug based on CAR T-Cell Forecast
10.3.3 Korea Market Drug based on CAR T-Cell Forecast
10.3.4 Southeast Asia Market Drug based on CAR T-Cell Forecast
10.3.5 India Market Drug based on CAR T-Cell Forecast
10.3.6 Australia Market Drug based on CAR T-Cell Forecast
10.4 Europe Drug based on CAR T-Cell Forecast by Country (2026-2031)
10.4.1 Germany Market Drug based on CAR T-Cell Forecast
10.4.2 France Market Drug based on CAR T-Cell Forecast
10.4.3 UK Market Drug based on CAR T-Cell Forecast
10.4.4 Italy Market Drug based on CAR T-Cell Forecast
10.4.5 Russia Market Drug based on CAR T-Cell Forecast
10.5 Middle East & Africa Drug based on CAR T-Cell Forecast by Region (2026-2031)
10.5.1 Egypt Market Drug based on CAR T-Cell Forecast
10.5.2 South Africa Market Drug based on CAR T-Cell Forecast
10.5.3 Israel Market Drug based on CAR T-Cell Forecast
10.5.4 Turkey Market Drug based on CAR T-Cell Forecast
10.6 Global Drug based on CAR T-Cell Forecast by Type (2026-2031)
10.7 Global Drug based on CAR T-Cell Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Drug based on CAR T-Cell Forecast
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Drug based on CAR T-Cell Product Offered
11.1.3 Novartis Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences Drug based on CAR T-Cell Product Offered
11.2.3 Gilead Sciences Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Gilead Sciences Main Business Overview
11.2.5 Gilead Sciences Latest Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Information
11.3.2 Bristol-Myers Squibb Drug based on CAR T-Cell Product Offered
11.3.3 Bristol-Myers Squibb Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Bristol-Myers Squibb Main Business Overview
11.3.5 Bristol-Myers Squibb Latest Developments
11.4 J & J
11.4.1 J & J Company Information
11.4.2 J & J Drug based on CAR T-Cell Product Offered
11.4.3 J & J Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 J & J Main Business Overview
11.4.5 J & J Latest Developments
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Information
11.5.2 JW Therapeutics Drug based on CAR T-Cell Product Offered
11.5.3 JW Therapeutics Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 JW Therapeutics Main Business Overview
11.5.5 JW Therapeutics Latest Developments
11.6 FOSUNKite
11.6.1 FOSUNKite Company Information
11.6.2 FOSUNKite Drug based on CAR T-Cell Product Offered
11.6.3 FOSUNKite Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 FOSUNKite Main Business Overview
11.6.5 FOSUNKite Latest Developments
11.7 CARsgen Therapeutics (Pipeline)
11.7.1 CARsgen Therapeutics (Pipeline) Company Information
11.7.2 CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Product Offered
11.7.3 CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 CARsgen Therapeutics (Pipeline) Main Business Overview
11.7.5 CARsgen Therapeutics (Pipeline) Latest Developments
11.8 CARsgen Therapeutics
11.8.1 CARsgen Therapeutics Company Information
11.8.2 CARsgen Therapeutics Drug based on CAR T-Cell Product Offered
11.8.3 CARsgen Therapeutics Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 CARsgen Therapeutics Main Business Overview
11.8.5 CARsgen Therapeutics Latest Developments
11.9 Autolus Therapeutics
11.9.1 Autolus Therapeutics Company Information
11.9.2 Autolus Therapeutics Drug based on CAR T-Cell Product Offered
11.9.3 Autolus Therapeutics Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Autolus Therapeutics Main Business Overview
11.9.5 Autolus Therapeutics Latest Developments
11.10 Sorrento Therapeutics
11.10.1 Sorrento Therapeutics Company Information
11.10.2 Sorrento Therapeutics Drug based on CAR T-Cell Product Offered
11.10.3 Sorrento Therapeutics Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Sorrento Therapeutics Main Business Overview
11.10.5 Sorrento Therapeutics Latest Developments
11.11 Mustang Bio
11.11.1 Mustang Bio Company Information
11.11.2 Mustang Bio Drug based on CAR T-Cell Product Offered
11.11.3 Mustang Bio Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Mustang Bio Main Business Overview
11.11.5 Mustang Bio Latest Developments
11.12 Bluebird Bio
11.12.1 Bluebird Bio Company Information
11.12.2 Bluebird Bio Drug based on CAR T-Cell Product Offered
11.12.3 Bluebird Bio Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Bluebird Bio Main Business Overview
11.12.5 Bluebird Bio Latest Developments
11.13 Cellectis
11.13.1 Cellectis Company Information
11.13.2 Cellectis Drug based on CAR T-Cell Product Offered
11.13.3 Cellectis Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Cellectis Main Business Overview
11.13.5 Cellectis Latest Developments
11.14 Allogene Therapeutics
11.14.1 Allogene Therapeutics Company Information
11.14.2 Allogene Therapeutics Drug based on CAR T-Cell Product Offered
11.14.3 Allogene Therapeutics Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Allogene Therapeutics Main Business Overview
11.14.5 Allogene Therapeutics Latest Developments
11.15 Celyad
11.15.1 Celyad Company Information
11.15.2 Celyad Drug based on CAR T-Cell Product Offered
11.15.3 Celyad Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Celyad Main Business Overview
11.15.5 Celyad Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Drug based on CART-Cell Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Drug based on CART-Cell Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of CD19-targeted
Table 4. Major Players of BCMA-targeted
Table 5. Drug based on CART-Cell Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Drug based on CART-Cell Market Size byType (2020-2025) & ($ millions)
Table 7. Global Drug based on CART-Cell Market Size Market Share byType (2020-2025)
Table 8. Drug based on CART-Cell Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Drug based on CART-Cell Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Drug based on CART-Cell Market Size Market Share by Application (2020-2025)
Table 11. Global Drug based on CART-Cell Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Drug based on CART-Cell Revenue Market Share by Player (2020-2025)
Table 13. Drug based on CART-Cell Key Players Head office and Products Offered
Table 14. Drug based on CART-Cell Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Drug based on CART-Cell Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Drug based on CART-Cell Market Size Market Share by Region (2020-2025)
Table 19. Global Drug based on CART-Cell Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Drug based on CART-Cell Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Drug based on CART-Cell Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Drug based on CART-Cell Market Size Market Share by Country (2020-2025)
Table 23. Americas Drug based on CART-Cell Market Size byType (2020-2025) & ($ millions)
Table 24. Americas Drug based on CART-Cell Market Size Market Share byType (2020-2025)
Table 25. Americas Drug based on CART-Cell Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Drug based on CART-Cell Market Size Market Share by Application (2020-2025)
Table 27. APAC Drug based on CART-Cell Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Drug based on CART-Cell Market Size Market Share by Region (2020-2025)
Table 29. APAC Drug based on CART-Cell Market Size byType (2020-2025) & ($ millions)
Table 30. APAC Drug based on CART-Cell Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Drug based on CART-Cell Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Drug based on CART-Cell Market Size Market Share by Country (2020-2025)
Table 33. Europe Drug based on CART-Cell Market Size byType (2020-2025) & ($ millions)
Table 34. Europe Drug based on CART-Cell Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Drug based on CART-Cell Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Drug based on CART-Cell Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa Drug based on CART-Cell Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Drug based on CART-Cell
Table 39. Key Market Challenges & Risks of Drug based on CART-Cell
Table 40. Key IndustryTrends of Drug based on CART-Cell
Table 41. Global Drug based on CART-Cell Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global Drug based on CART-Cell Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global Drug based on CART-Cell Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global Drug based on CART-Cell Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45. Novartis Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 46. Novartis Drug based on CART-Cell Product Offered
Table 47. Novartis Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Novartis Main Business
Table 49. Novartis Latest Developments
Table 50. Gilead Sciences Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 51. Gilead Sciences Drug based on CART-Cell Product Offered
Table 52. Gilead Sciences Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Gilead Sciences Main Business
Table 54. Gilead Sciences Latest Developments
Table 55. Bristol-Myers Squibb Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 56. Bristol-Myers Squibb Drug based on CART-Cell Product Offered
Table 57. Bristol-Myers Squibb Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Bristol-Myers Squibb Main Business
Table 59. Bristol-Myers Squibb Latest Developments
Table 60. J & J Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 61. J & J Drug based on CART-Cell Product Offered
Table 62. J & J Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. J & J Main Business
Table 64. J & J Latest Developments
Table 65. JWTherapeutics Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 66. JWTherapeutics Drug based on CART-Cell Product Offered
Table 67. JWTherapeutics Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. JWTherapeutics Main Business
Table 69. JWTherapeutics Latest Developments
Table 70.FOSUNKite Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 71.FOSUNKite Drug based on CART-Cell Product Offered
Table 72.FOSUNKite Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73.FOSUNKite Main Business
Table 74.FOSUNKite Latest Developments
Table 75. CARsgenTherapeutics (Pipeline) Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 76. CARsgenTherapeutics (Pipeline) Drug based on CART-Cell Product Offered
Table 77. CARsgenTherapeutics (Pipeline) Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. CARsgenTherapeutics (Pipeline) Main Business
Table 79. CARsgenTherapeutics (Pipeline) Latest Developments
Table 80. CARsgenTherapeutics Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 81. CARsgenTherapeutics Drug based on CART-Cell Product Offered
Table 82. CARsgenTherapeutics Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. CARsgenTherapeutics Main Business
Table 84. CARsgenTherapeutics Latest Developments
Table 85. AutolusTherapeutics Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 86. AutolusTherapeutics Drug based on CART-Cell Product Offered
Table 87. AutolusTherapeutics Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. AutolusTherapeutics Main Business
Table 89. AutolusTherapeutics Latest Developments
Table 90. SorrentoTherapeutics Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 91. SorrentoTherapeutics Drug based on CART-Cell Product Offered
Table 92. SorrentoTherapeutics Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. SorrentoTherapeutics Main Business
Table 94. SorrentoTherapeutics Latest Developments
Table 95. Mustang Bio Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 96. Mustang Bio Drug based on CART-Cell Product Offered
Table 97. Mustang Bio Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Mustang Bio Main Business
Table 99. Mustang Bio Latest Developments
Table 100. Bluebird Bio Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 101. Bluebird Bio Drug based on CART-Cell Product Offered
Table 102. Bluebird Bio Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Bluebird Bio Main Business
Table 104. Bluebird Bio Latest Developments
Table 105. Cellectis Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 106. Cellectis Drug based on CART-Cell Product Offered
Table 107. Cellectis Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Cellectis Main Business
Table 109. Cellectis Latest Developments
Table 110. AllogeneTherapeutics Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 111. AllogeneTherapeutics Drug based on CART-Cell Product Offered
Table 112. AllogeneTherapeutics Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. AllogeneTherapeutics Main Business
Table 114. AllogeneTherapeutics Latest Developments
Table 115. Celyad Details, CompanyType, Drug based on CART-Cell Area Served and Its Competitors
Table 116. Celyad Drug based on CART-Cell Product Offered
Table 117. Celyad Drug based on CART-Cell Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Celyad Main Business
Table 119. Celyad Latest Developments
LIST OFFIGURES
Figure 1. Drug based on CART-Cell Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drug based on CART-Cell Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Drug based on CART-Cell Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Drug based on CART-Cell Sales Market Share by Country/Region (2024)
Figure 8. Drug based on CART-Cell Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Drug based on CART-Cell Market Size Market Share byType in 2024
Figure 10. Drug based on CART-Cell in Lymphoma
Figure 11. Global Drug based on CART-Cell Market: Lymphoma (2020-2025) & ($ millions)
Figure 12. Drug based on CART-Cell in Multiple Myeloma
Figure 13. Global Drug based on CART-Cell Market: Multiple Myeloma (2020-2025) & ($ millions)
Figure 14. Global Drug based on CART-Cell Market Size Market Share by Application in 2024
Figure 15. Global Drug based on CART-Cell Revenue Market Share by Player in 2024
Figure 16. Global Drug based on CART-Cell Market Size Market Share by Region (2020-2025)
Figure 17. Americas Drug based on CART-Cell Market Size 2020-2025 ($ millions)
Figure 18. APAC Drug based on CART-Cell Market Size 2020-2025 ($ millions)
Figure 19. Europe Drug based on CART-Cell Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Drug based on CART-Cell Market Size 2020-2025 ($ millions)
Figure 21. Americas Drug based on CART-Cell Value Market Share by Country in 2024
Figure 22. United States Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Drug based on CART-Cell Market Size Market Share by Region in 2024
Figure 27. APAC Drug based on CART-Cell Market Size Market Share byType (2020-2025)
Figure 28. APAC Drug based on CART-Cell Market Size Market Share by Application (2020-2025)
Figure 29. China Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 33. India Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Drug based on CART-Cell Market Size Market Share by Country in 2024
Figure 36. Europe Drug based on CART-Cell Market Size Market Share byType (2020-2025)
Figure 37. Europe Drug based on CART-Cell Market Size Market Share by Application (2020-2025)
Figure 38. Germany Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 39.France Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Drug based on CART-Cell Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Drug based on CART-Cell Market Size Market Share byType (2020-2025)
Figure 45. Middle East & Africa Drug based on CART-Cell Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 49.Turkey Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Drug based on CART-Cell Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 52. APAC Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 53. Europe Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 55. United States Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 56. Canada Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 57. Mexico Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 58. Brazil Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 59. China Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 60. Japan Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 61. Korea Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 63. India Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 64. Australia Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 65. Germany Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 66.France Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 67. UK Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 68. Italy Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 69. Russia Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 70. Egypt Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 71. South Africa Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 72. Israel Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 73.Turkey Drug based on CART-Cell Market Size 2026-2031 ($ millions)
Figure 74. Global Drug based on CART-Cell Market Size Market ShareForecast byType (2026-2031)
Figure 75. Global Drug based on CART-Cell Market Size Market ShareForecast by Application (2026-2031)
Figure 76. GCC Countries Drug based on CART-Cell Market Size 2026-2031 ($ millions)
More Publications
Global Extremity Products Market Growth 2024-2030
US$ 3,660.00
November 2024
134 pages
Global Cortical Grid Electrodes Market Growth 2023-2029
US$ 3,660.00
January 2023
98 pages
Global API Intermediate Market Growth 2025-2031
US$ 3,660.00
October 2025
142 pages
Global Transcatheter Intervention Devices Market Growth 2024-2030
US$ 3,660.00
December 2023
131 pages
Global Vitamin and Mineral Supplement for Pregnancy Market Growth 2024-2030
US$ 3,660.00
December 2023
115 pages
